Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $1.80 billion. The enterprise value is $1.56 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 446.50 million shares outstanding. The number of shares has increased by 25.40% in one year.
| Current Share Class | 446.50M |
| Shares Outstanding | 446.50M |
| Shares Change (YoY) | +25.40% |
| Shares Change (QoQ) | +2.84% |
| Owned by Insiders (%) | 6.62% |
| Owned by Institutions (%) | 54.12% |
| Float | 387.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.41 |
| Forward PS | 4.60 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.60 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.51% and return on invested capital (ROIC) is -28.13%.
| Return on Equity (ROE) | -47.51% |
| Return on Assets (ROA) | -23.65% |
| Return on Invested Capital (ROIC) | -28.13% |
| Return on Capital Employed (ROCE) | -44.97% |
| Weighted Average Cost of Capital (WACC) | 7.88% |
| Revenue Per Employee | $292,931 |
| Profits Per Employee | -$362,933 |
| Employee Count | 975 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.79 |
Taxes
| Income Tax | -898,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.29% in the last 52 weeks. The beta is 0.70, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +134.29% |
| 50-Day Moving Average | 3.66 |
| 200-Day Moving Average | 2.88 |
| Relative Strength Index (RSI) | 57.54 |
| Average Volume (20 Days) | 15,402,200 |
Short Selling Information
The latest short interest is 106.61 million, so 23.88% of the outstanding shares have been sold short.
| Short Interest | 106.61M |
| Short Previous Month | 114.71M |
| Short % of Shares Out | 23.88% |
| Short % of Float | 27.48% |
| Short Ratio (days to cover) | 7.03 |
Income Statement
In the last 12 months, IOVA had revenue of $285.61 million and -$353.86 million in losses. Loss per share was -$0.93.
| Revenue | 285.61M |
| Gross Profit | 112.64M |
| Operating Income | -358.04M |
| Pretax Income | -354.76M |
| Net Income | -353.86M |
| EBITDA | -321.62M |
| EBIT | -358.04M |
| Loss Per Share | -$0.93 |
Full Income StatementBalance Sheet
The company has $313.44 million in cash and $47.78 million in debt, with a net cash position of $265.67 million or $0.60 per share.
| Cash & Cash Equivalents | 313.44M |
| Total Debt | 47.78M |
| Net Cash | 265.67M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 721.75M |
| Book Value Per Share | 1.65 |
| Working Capital | 337.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$270.79 million and capital expenditures -$34.23 million, giving a free cash flow of -$305.02 million.
| Operating Cash Flow | -270.79M |
| Capital Expenditures | -34.23M |
| Depreciation & Amortization | 36.41M |
| Net Borrowing | n/a |
| Free Cash Flow | -305.02M |
| FCF Per Share | -$0.68 |
Full Cash Flow StatementMargins
Gross margin is 39.44%, with operating and profit margins of -125.36% and -123.90%.
| Gross Margin | 39.44% |
| Operating Margin | -125.36% |
| Pretax Margin | -124.21% |
| Profit Margin | -123.90% |
| EBITDA Margin | -112.61% |
| EBIT Margin | -125.36% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.40% |
| Shareholder Yield | -25.40% |
| Earnings Yield | -19.33% |
| FCF Yield | -16.66% |
Analyst Forecast
The average price target for IOVA is $8.80, which is 118.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.80 |
| Price Target Difference | 118.09% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 41.36% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of -2.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.04 |
| Piotroski F-Score | 2 |
